Picture of CellaVision AB logo

CEVI CellaVision AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for CellaVision AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line158148164177194
Depreciation
Non-Cash Items8.584.699.6222.140.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-40.6-55.9-17.2-41.6-34.6
Change in Accounts Receivable
Change in Inventories
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities160137196198201
Capital Expenditures-52.5-69.2-86.5-77.7-86.3
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items-31.8-0.7810.9441.740.109
Acquisition of Business
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-84.3-70-85.5-76-86.2
Financing Cash Flow Items0.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-48.5-90.4-97-95.1-74.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash28-22.213.627.838.8